// App-Quantinova.ai

1125 : Intratumoral administration of SARS-CoV-2 reduces tumor progression and alters the tumor immune microenvironment similar to that of the seasonal influenza vaccine

Researchers

Presenter

  • Eileena Giurini

Principal Investigators

  • Kajal Gupta

Medical Centers

  • Rush University Medical Center, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

Disease

  • Breast cancer

  • Influenza

  • Melanoma

  • Solid malignancies

Biomarkers

  • Translocator protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved